Matthew W.

Matthew W. has a diverse work experience. Matthew started as a Research Biochemist at Turing Pharmaceuticals AG in June 2015 and worked until October 2015. In October 2015, they went on to become a Consultant and Founder at Atoms 2 Applications, LLC until December 2016. In August 2016, they served as an Adjunct Professor at Kean University until December 2016. In December 2016, they joined Kleo Pharmaceuticals Inc. as a Principal Scientist until October 2017. Matthew then became the Director of Chemical Biology at the same company. Additionally, they are a Founder and Board Member of A2A Pharmaceuticals since 2016.

Matthew W. completed their education from 2006 to 2009 at The Ohio State University, where they earned a Bachelor of Science (B.S.) degree in Biochemistry. Following this, they pursued further studies at Columbia University from 2009 to 2015. At Columbia, Matthew obtained a Doctor of Philosophy (Ph.D.), a Master of Philosophy (M.Phil.), and a Master of Arts (M.A.) degree in Chemistry.